Listen Now

In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

In this podcast Dr. Anders Carlson from the University of Minnesota Medical School discusses the clinical implications of continuous glucose monitoring (CGM) in patients with type 2 diabetes.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

In this podcast Drs. Amisha Wallia and Susan Karam discuss clinical insights to managing elderly patients with T2DM.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

In this podcast Dr. Clare Lee from Johns Hopkins discussed Insulin Intensification with OADs.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

In this podcast, Dr. Nestoras Mathioudakis from Johns Hopkins University School of Medicine discusses how the focus on cardiovascular outcomes can impact current clinical practice when managing patients with type 2 diabetes.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

Nestoras Mathioudakis, MD covers the important topic of the Dietary Recommendations for Patients with Diabetes in the format of case-study scenarios for the clinical practice. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 13, Part 3.Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Glargine (Lantus) in Type 2 Diabetes, presented at the June 2016 American Diabetes Association Scientific Session.The post Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D) appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 13, Part 2.Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Jeffrey I. Mechanick from the Icahn School of Medicine at Mt. Sinai about his presentation: A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care, presented at the May 2016 AACE Annual Scientific and Clinical Congress.The post A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 13, Part 1.Nestoras Mathioudakis, MD, MD from Johns Hopkins interviews Dr. Sethu Reddy from Cleveland Clinic about the seminar: Inpatient Glycemic Management: From Bedside to the Cloud presented at the May 2016 AACE Annual Scientific and Clinical Congress.The post Inpatient Glycemic Management: From the Bedside to the Cloud appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 11.Anne Peters, MD covers the important topic of Risks and Benefits of SGLT-2 Inhibitor Agents in the format of case-study scenarios for the clinical practice.The post Risks and Benefits of SGLT-2 Inhibitor Agents appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 9.Clare J. Lee, MD, MHS covers the important topic of the Clinical Use of Fixed-Dose OADs in the format of case-study scenarios for the clinical practice.The post The Clinical Use of Fixed-Dose OADs appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 7.Marc Rendell, MD covers the important topic of the Safety of the Newer Oral Diabetes Treatment Agents in the format of case-study scenarios for the clinical practice.The post Safety of the Newer Oral Diabetes Treatment Agents appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 5.Susan Porter, MSN, CRNP, CDE covers the important topic of patient-centered care in the format of case-study scenarios for the clinical practice.The post Improving Patient-Centered Care in the Clinic appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 3.Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.The post Beyond Basal Insulin: GLP-1 Receptor Agonists in Combination appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 1 – Part  3.Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.The post 2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 3 appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 1 – Part  2.Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Jennifer Green from Duke University Medical Center about the TECOS study.The post 2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 2 appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 1 – Part  1.Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Andrew Ahmann from the Oregon Health and Science University about the FLAT-SUGAR trial.The post 2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 1 appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 1, Issue 12.Nestoras Mathioudakis, MD, Assistant Professor of Medicine, and Om Ganda, MD, Associate Professor of Medicine cover the important topic of therapeutic advances in type 2 diabetes treatment in the format of case-study scenarios for the clinical practice.The post Therapeutic Advances in Type 2 Diabetes Treatment appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 1, Issue 10.Dr. Clare J. Lee from Johns Hopkins University School of Medicine, covers the important topic of the management of overweight and obese patients with type 2 diabetes.The post Management of Overweight and Obese Patients with T2DM appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.